Prosecution Insights
Last updated: August 16, 2026

University of Utah Research Foundation

42 pending office actions • 30 art units • 42 examiners • 0 of 42 (0%) have an AI response strategy ready • 42 patents granted in the last 365 days

Portfolio Summary

42
Total Pending OAs
27
Non-Final OAs
15
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 14 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

10
Overdue
1
Due this week
2
Due this month
1
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 14 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (10)Due ≤ 7 days (1)Due ≤ 30 days (2)Due ≤ 60 days (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

14
Hard (33%)
23
Medium (55%)
5
Easy (12%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 only1 (2%)
§101 + other3 (7%)
§103 only16 (38%)
§102 only3 (7%)
§112 only2 (5%)
Double-patenting only3 (7%)
Double-patenting + other4 (10%)
Multi-statute (no §101)10 (24%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

25
Life Sciences
60% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
1
Semiconductors
2% of docket
9
Mechanical / Eng
21% of docket
7
Business / Other
17% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

420 h
Manual time on pending OAs
84 h
Time saved (low, 20%)
147 h
Time saved (mid, 35%)
3.7 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
BRUTUS, JOEL F 1 72.6% +17.9%
MATTHEWS, MADISON ROSE 1 80.1% +35.4%
ROE, JESSEE RANDALL 1 76.3% +7.8%
ABDUR, RAHMAN 1 73.8% +18.2%
WILLSE, DAVID H 1 67.6% +13.2%
ALAOUIE, ALI MUSTAFA 1
RILEY, JEZIA 1 82.9% +7.3%
RUBY, TRAVIS C 1 53.5% +27.8%
BERA, HENA RAKESHKUMAR 1
GROOMS, TIFFANY NICOLE 1 58.8% +46.8%

Quick Wins (2)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18968893 TRAUMA GURNEY WITH ENHANCED PATIENT TRANSFER CAPABILITIES MATTHEWS, MADISON ROSE 18d overdue
18687723 HYBRIDIZATION PROBES CONTAINING FLUORINATED CARBON CHAINS AND RELATED METHODS RILEY, JEZIA

Hard Cases (14)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17929062 ASSESSMENT OF MELANOMA THERAPY RESPONSE GRAY, JESSICA 44d overdue
18202764 LUNG-ON-CHIP DEVICE WITH INTEGRATED EXTRACELLULAR MATRIX MEMBRANE YOH, JULIUS FRANCIS 18d overdue
17594643 METABOLIC ENGINEERING OF NON-PATHOGENIC ESCHERICHIA COLI STRAINS FOR THE CONTROLLED PRODUCTION OF LOW MOLECULAR WEIGHT HEPAROSAN AND SIZE-SPECIFIC HEPAROSAN OLIGOSACCHARIDES ESPINOSA, CLAUDIA EDILMA 4d overdue
17796494 HIGH MOLECULAR WEIGHT HEPARIN COMPOSITIONS AND METHODS FOR DIAGNOSING, TREATING AND MONITORING EOSINOPHIL MEDIATED INFLAMMATORY DISEASES MEJIAS, SAMANTHA LEE 2d overdue
17801002 METHODS FOR REHABILITATING HEART FAILURE USING GENE THERAPY AFREMOVA, VERA 7d
18075680 REAL-TIME COORDINATED OPERATION OF POWER AND ELECTRIC RIDE SYSTEMS HENZE, DAVID V 13d
18098538 THERAPEUTIC DELIVERY DEVICE VU, QUYNH-NHU HOANG 33d
18797238 SYSTEM AND METHOD FOR QUANTITATIVE PHASE IMAGING FOR MULTI-PARAMETRIC SCREENING OF TUMOR THERAPY RESPONSE ABDUR, RAHMAN

Interview Candidates (6)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.

App #TitleExaminerDue in
18968893 TRAUMA GURNEY WITH ENHANCED PATIENT TRANSFER CAPABILITIES MATTHEWS, MADISON ROSE 18d overdue
19244668 IMPLANTABLE AND BIODEGRADABLE SMART HYDROGEL MICROMECHANICAL RESONATORS WITH ULTRASOUND READOUT BRUTUS, JOEL F
18797238 SYSTEM AND METHOD FOR QUANTITATIVE PHASE IMAGING FOR MULTI-PARAMETRIC SCREENING OF TUMOR THERAPY RESPONSE ABDUR, RAHMAN
18774524 Variable Transmission For Assistive Prosthesis Device WILLSE, DAVID H
18410702 HEAT EXCHANGERS, SYSTEMS AND METHODS OF USING THE SAME RUBY, TRAVIS C
18573350 COMPOSITIONS AND METHODS FOR TREATING PGM1 DEFICIENCY GROOMS, TIFFANY NICOLE

Top Art Units

Art UnitApps
1658 2
1642 2
1653 2
1682 2
1654 2
3797 1
3673 1
1759 1
3763 1
1733 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19244668 IMPLANTABLE AND BIODEGRADABLE SMART HYDROGEL MICROMECHANICAL RESONATORS WITH ULTRASOUND READOUT BRUTUS, JOEL F 3797 §103Other Non-Final OA Pending Jun 20, 2025
18968893 TRAUMA GURNEY WITH ENHANCED PATIENT TRANSFER CAPABILITIES MATTHEWS, MADISON ROSE 3673 §103 Final Rejection 18d overdue Pending Dec 04, 2024
18819806 Thermo-Hydrogen Refinement of Microstructure of Titanium Materials ROE, JESSEE RANDALL 1759 §112 Final Rejection Pending Aug 29, 2024
18797238 SYSTEM AND METHOD FOR QUANTITATIVE PHASE IMAGING FOR MULTI-PARAMETRIC SCREENING OF TUMOR THERAPY RESPONSE ABDUR, RAHMAN §102§103 Non-Final OA Pending Aug 07, 2024
18774524 Variable Transmission For Assistive Prosthesis Device WILLSE, DAVID H §112 Non-Final OA Pending Jul 16, 2024
18744116 COMPOSITIONS AND METHODS FOR TREATING SIALORRHEA ALAOUIE, ALI MUSTAFA §103§112DP Non-Final OA Pending Jun 14, 2024
18687723 HYBRIDIZATION PROBES CONTAINING FLUORINATED CARBON CHAINS AND RELATED METHODS RILEY, JEZIA §102 Non-Final OA Pending Feb 28, 2024
18410702 HEAT EXCHANGERS, SYSTEMS AND METHODS OF USING THE SAME RUBY, TRAVIS C 3763 §102§103 Final Rejection Pending Jan 11, 2024
18407655 VOLATILE COMPOUND SOURCE LOCATING SYSTEMS BERA, HENA RAKESHKUMAR §103Other Non-Final OA Pending Jan 09, 2024
18573350 COMPOSITIONS AND METHODS FOR TREATING PGM1 DEFICIENCY GROOMS, TIFFANY NICOLE §103 Non-Final OA Pending Dec 21, 2023
18537497 THREE-DIMENSIONAL PERCOLATION ARRAY STRUCTURE AS A GAS SENSOR HANDY, DWAYNE K §102§103Other Non-Final OA Pending Dec 12, 2023
18567010 SELECTIVE PENICILLAMINE SUBSTITUTION ENABLES DEVELOPMENT OF A POTENT ANALGESIC PEPTIDE THAT ACTS THROUGH A NON-OPIOID BASED MECHANISM REYNOLDS, FRED H 1658 §102§103§112DP Non-Final OA Pending Dec 04, 2023
18518857 SINTERED TITANIUM COMPONENTS AND ADDITIVE MANUFACTURING METHODS THEREOF JANSSEN, REBECCA 1733 §103 Non-Final OA Pending Nov 24, 2023
18375485 CANNULATED CONTINUOUS COMPRESSION SCREW COLEY, ZADE JAMES 3775 §103 Non-Final OA Pending Sep 30, 2023
18546258 TREATMENT OF MYOPIA HUANG, GIGI GEORGIANA 1613 DP Non-Final OA 21d Pending Aug 11, 2023
18262522 PNMA2-BASED CAPSIDS AND USES THEREOF BARRERA, IMMACULADA 1671 §103 Final Rejection Pending Jul 21, 2023
18352014 POLYESTER NETWORKS FROM STRUCTURALLY SIMILAR MONOMERS: RECYCLABLE-BY-DESIGN AND UPCYCLABLE TO PHOTOPOLYMERS RUNYAN, SILVANA C 3674 §103 Non-Final OA Pending Jul 13, 2023
18212168 BIOHAZARD ANALYZER LUSI, ELLIS FOLLETT 1672 §103§112 Non-Final OA Pending Jun 20, 2023
18328609 OCULAR TISSUE SAMPLING DEVICE GERHARD, ALISON CLAIRE 1797 §103 Non-Final OA Pending Jun 02, 2023
18324773 Zwitterion Polymer-Drug Conjugates MOSELEY II, NELSON B 1642 §102§103 Non-Final OA Pending May 26, 2023
18202764 LUNG-ON-CHIP DEVICE WITH INTEGRATED EXTRACELLULAR MATRIX MEMBRANE YOH, JULIUS FRANCIS 1799 §102§103 Non-Final OA 18d overdue Pending May 26, 2023
18032790 Powered Joint System with Enhanced Neural-Based Controller PATEL, AREN 3774 §102§103 Final Rejection Pending Apr 19, 2023
18117316 ELECTRIC GRIP GAUGE FOR ASSESSING HAND DEXTERITY EISEMAN, ADAM JARED 3791 §103 Non-Final OA 8d overdue Pending Mar 03, 2023
18043792 SYSTEMS AND METHODS FOR CONTROLLING BACTERIAL TRANSCRIPTION REGA, KYLE THOMAS 1636 §103 Final Rejection 5d overdue Pending Mar 02, 2023
18098538 THERAPEUTIC DELIVERY DEVICE VU, QUYNH-NHU HOANG 3783 §102§103 Non-Final OA 33d Pending Jan 18, 2023
18010580 BIOMARKER BASED PATIENT SELECTION FOR PROTEASOME INHIBITOR TREATMENT AEDER, SEAN E 1642 §102 Non-Final OA Pending Dec 15, 2022
18009973 RETINAL BIOAVAILBILITY OF SYNTHETIC VERY-LONG-CHAIN POLYUNSATURATED FATTY ACIDS NEAGU, IRINA 1629 §101§103§112 Non-Final OA Pending Dec 12, 2022
18075680 REAL-TIME COORDINATED OPERATION OF POWER AND ELECTRIC RIDE SYSTEMS HENZE, DAVID V 2859 §101 Final Rejection 13d Pending Dec 06, 2022
17911624 METHOD FOR TREATING LUNG DISEASE WITH CELL-FREE AMNIOTIC FLUID TICHY, JENNIFER M.H. 1653 §102§112DP Final Rejection Pending Sep 14, 2022
17929062 ASSESSMENT OF MELANOMA THERAPY RESPONSE GRAY, JESSICA 1682 §101§103§112 Final Rejection 44d overdue Pending Sep 01, 2022
17900240 IMPLANTABLE BONE SCAFFOLDS INCLUDING AT LEAST ONE INTEGRATION AID, METHODS OF MAKING AND USING THE SAME LIU, TRACY 1614 DP Non-Final OA 35d overdue Pending Aug 31, 2022
17801002 METHODS FOR REHABILITATING HEART FAILURE USING GENE THERAPY AFREMOVA, VERA 1653 §102§103 Final Rejection 7d Pending Aug 19, 2022
17796494 HIGH MOLECULAR WEIGHT HEPARIN COMPOSITIONS AND METHODS FOR DIAGNOSING, TREATING AND MONITORING EOSINOPHIL MEDIATED INFLAMMATORY DISEASES MEJIAS, SAMANTHA LEE 1618 §101§103§112 Non-Final OA 2d overdue Pending Jul 29, 2022
17771053 Zero Power Visible Colorimetric Pathogen Sensors SVEIVEN, MICHAEL CAMERON 1678 §102 Final Rejection Pending Apr 22, 2022
17766489 TARGETED SEQUENCING TO DETECT AND QUANTIFY LOW LEVELS OF METHYLATED DNA DAUNER, JOSEPH G 1682 §103 Final Rejection Pending Apr 04, 2022
17760668 Conformationally-Constrained Alpha-RGIA Analogues STEELE, AMBER D 1658 §102§103§112DP Non-Final OA Pending Mar 15, 2022
17640627 COMPOSITIONS AND METHODS FOR USING SILK-ELASTINLIKE PROTEIN-BASED POLYMERS FONTAINHAS, AURORA M 1675 §103 Final Rejection 113d overdue Pending Mar 04, 2022
17626469 MULTI-AGENT OCULAR FORMULATIONS AND TREATMENT METHODS PIPIC, ALMA 1617 §103Other Final Rejection Pending Jan 11, 2022
17616111 NOVEL LIVE-CELL ASSAY FOR NEURONAL ACTIVITY NICOL, ALEXANDER W 1634 §103 Non-Final OA 2d overdue Pending Dec 02, 2021
17528853 MICRO-MOLDED ELECTRODES, ARRAYS, AND METHODS OF MAKING THE SAME CAZAN, LIVIUS RADU 3729 §103 Non-Final OA Pending Nov 17, 2021
17594643 METABOLIC ENGINEERING OF NON-PATHOGENIC ESCHERICHIA COLI STRAINS FOR THE CONTROLLED PRODUCTION OF LOW MOLECULAR WEIGHT HEPAROSAN AND SIZE-SPECIFIC HEPAROSAN OLIGOSACCHARIDES ESPINOSA, CLAUDIA EDILMA 1654 §103§112 Final Rejection 4d overdue Pending Oct 25, 2021
17348694 DIMERIC COLLAGEN HYBRIDIZING PEPTIDES AND METHODS OF USE THEREOF SABILA, MERCY HELLEN 1654 DP Non-Final OA Pending Jun 15, 2021

Managing University of Utah Research Foundation's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month